Abstract
With falling prices of antiretroviral drugs in countries like India, there has been an increasing awareness that antiretroviral therapy can be made available and accessible to a large number of HIV-positive individuals. Prices, however, still remain high enough to keep ART out of reach of a majority of affected individuals in India. This study analyses the demand for antiretroviral therapy (ART) using a contingent valuation approach, by estimating the willingness to pay for ART among a sample of HIV positive individuals in India. The study finds a very high willingness to be on ART, but substantially lower willingness to pay for it. To cover 70 percent of patients would require the price to be around Rs. 500 per month. Economic status generally and of females in particular have a positive relationship with the willingness to pay for drugs, whereas being a female exerts a downward pressure on the demand for ART.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
